Why the study?
Does beta-blocker therapy reduce one-year all-cause mortality in post-infarction patients?
Population
13,679 post-infarction patients pooled from 9 randomized trials
Comparison
Beta-blocker therapy vs Placebo
Design
Meta-analysis
Follow-up
One-year
Loading...
Supports routine beta-blocker use post-MI; confirms mortality benefit in updated Level 1 evidence.
Does beta-blocker therapy reduce one-year all-cause mortality in post-infarction patients?
Beta-blocker therapy reduces one-year all-cause mortality by 24% in post-infarction patients, with the greatest absolute benefit observed in high-risk subgroups.
A 1988 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: